Respiri Limited (AU:RSH) has released an update.
Respiri Limited is on track for profitability in 2024, with a significant increase in both patient and client numbers, and an enhanced ‘Clinic in Cloud’ system promising improved efficiency. The company boasts a robust pipeline, including a risk-share component, indicating a strategic growth plan. However, investors are cautioned regarding forward-looking statements that are subject to the usual risks and uncertainties of tech and business development.
For further insights into AU:RSH stock, check out TipRanks’ Stock Analysis page.
